ETON
Eton Pharmaceuticals Inc

5,626
Mkt Cap
$406.02M
Volume
247,977.00
52W High
$23.00
52W Low
$11.09
PE Ratio
-60.78
ETON Fundamentals
Price
$15.14
Prev Close
$15.41
Open
$15.39
50D MA
$16.52
Beta
0.81
Avg. Volume
228,153.68
EPS (Annual)
-$0.1476
P/B
17.56
Rev/Employee
$1.26M
Loading...
Loading...
News
all
press releases
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Hold" by Brokerages
Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have been given an average rating of "Hold" by the five ratings firms that are covering the firm, Marketbeat reports. One equities...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research
Zacks Research raised shares of Eton Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...
MarketBeat·17d ago
News Placeholder
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are covering the company, Marketbeat reports. Two equities...
MarketBeat·28d ago
News Placeholder
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Wall Street Zen to Hold
Wall Street Zen downgraded shares of Eton Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Estimate for ETON FY2025 Earnings?
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Eton Pharmaceuticals in a research report issued on...
MarketBeat·1mo ago
News Placeholder
Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst
Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Research analysts at HC Wainwright cut their Q4 2026 EPS estimates for Eton Pharmaceuticals in a note issued to investors on Tuesday, December...
MarketBeat·1mo ago
News Placeholder
Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON
Divisadero Street Capital Management LP acquired a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·1mo ago
News Placeholder
Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON
Geode Capital Management LLC increased its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 98.8% in the 2nd quarter, according to the company in its most recent filing...
MarketBeat·2mo ago
News Placeholder
Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON
Diametric Capital LP lifted its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 333.0% in the 2nd quarter, according to its most recent filing with the Securities...
MarketBeat·2mo ago
News Placeholder
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Consensus Rating of "Hold" from Analysts
Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have received a consensus recommendation of "Hold" from the five research firms that are presently covering the stock...
MarketBeat·2mo ago
<
1
2
...
>

Latest ETON News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.